Lisa Trivison Beck
Corporate Officer/Principal bei BRII BIOSCIENCES LIMITED
Profil
Lisa Trivison Beck is currently the Senior Vice President-Business Development at Brii Biosciences Ltd.
(China) since 2019.
Prior to this, she worked at Alexion Pharmaceuticals, Inc. as the Head-Transactions & Alliance Management from 2015 to 2018.
She also worked at GSK Plc for 24 years from 1991 to 2015, where she held the position of Director-Portfolio Management.
Ms. Beck completed her undergraduate degree from Vanderbilt University in 1984.
Aktive Positionen von Lisa Trivison Beck
| Unternehmen | Position | Beginn |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 17.12.2019 |
Ehemalige bekannte Positionen von Lisa Trivison Beck
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2018 |
| GSK PLC | Corporate Officer/Principal | 01.08.2015 |
Ausbildung von Lisa Trivison Beck
| Vanderbilt University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| GSK PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
